---
figid: PMC5601165__oncotarget-08-60589-g002
figtitle: 'Genetic progression in gastrointestinal stromal tumors: mechanisms and
  molecular interventions'
organisms:
- Homo sapiens
- Mus musculus
- NA
pmcid: PMC5601165
filename: oncotarget-08-60589-g002.jpg
figlink: /pmc/articles/PMC5601165/figure/F2/
number: F2
caption: The kinase activation of KIT or PDGFRA stimulates downstream signaling pathways,
  including the MAPK pathway, the PI3K-AKT pathway and the STAT3 pathway. Imatinib,
  sunitinib and regorafenib inhibit several kinases, including KIT and PDGFRA, by
  binding to the ATP-pocket and yield durable responses.
papertitle: 'Genetic progression in gastrointestinal stromal tumors: mechanisms and
  molecular interventions.'
reftext: Ke Li, et al. Oncotarget. 2017 Sep 1;8(36):60589-60604.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9518857
figid_alias: PMC5601165__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC5601165__F2
ndex: a9a3c347-deb5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5601165__oncotarget-08-60589-g002.html
  '@type': Dataset
  description: The kinase activation of KIT or PDGFRA stimulates downstream signaling
    pathways, including the MAPK pathway, the PI3K-AKT pathway and the STAT3 pathway.
    Imatinib, sunitinib and regorafenib inhibit several kinases, including KIT and
    PDGFRA, by binding to the ATP-pocket and yield durable responses.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pdgfra
  - Kit
  - ras
  - Hras
  - Kras
  - Rem1
  - Shc1
  - Pik3r1
  - Src
  - Zhx2
  - Mos
  - Mocos
  - Map3k8
  - Tpi-rs2
  - Akt1
  - Map2k1
  - Map2k2
  - Stat3
  - Mtor
  - Mapk3
  - Mapk1
  - Myc
  - Nol3
  - PDGFRA
  - KIT
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SRC
  - FGR
  - FYN
  - YES1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MOS
  - MOCOS
  - MAP3K8
  - AKT1
  - AKT2
  - AKT3
  - MAP2K1
  - MAP2K2
  - STAT3
  - MTOR
  - MAPK3
  - MAPK1
  - MYC
  - Regorafenib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
